Ventricular fibrillation (VF) is a common initial rhythm in both out-of-hospital and in-hospital cardiac arrest and remains one of the most immediately life-threatening arrhythmias encountered in acute care. Defibrillation combined with high-quality cardiopulmonary resuscitation (CPR) is the cornerstone of treatment. However, a substantial proportion of patients remain in shock-refractory ventricular fibrillation, defined as persistent VF despite multiple appropriately delivered defibrillation attempts.

This simulation depicts the management of refractory ventricular fibrillation, with particular emphasis on evidence-based escalation strategies when standard defibrillation fails.

Pulseless ventricular fibrillation is treated using the Advanced Cardiac Life Support (ACLS) cardiac arrest algorithm, which prioritizes early defibrillation, uninterrupted high-quality CPR, and rapid identification of reversible causes.

Key components of the pulseless VF / pulseless VT algorithm include:

1. Immediate High-Quality CPR

• Chest compressions at 100–120/min

• Compression depth 5–6 cm in adults

• Full chest recoil and minimal interruptions

• Early airway management without delaying defibrillation

High chest compression fraction and minimizing pre- and post-shock pauses are strongly associated with improved outcomes.

2. Early Defibrillation

• Immediate unsynchronized biphasic defibrillation as soon as VF is identified

• Subsequent shocks delivered every 2 minutes, coordinated with rhythm checks

• Pads typically placed in the anterior–lateral position for initial shocks

3. Vasopressor Therapy

• Epinephrine 1 mg IV/IO every 3–5 minutes after the second defibrillation attempt

• Intended to improve coronary and cerebral perfusion pressure during CPR

4. Antiarrhythmic Therapy

• Amiodarone or lidocaine may be administered for persistent VF after multiple shocks

• These agents reduce recurrence of VF but have not consistently demonstrated improvement in survival to hospital discharge

5. Identification of Reversible Causes

• Ongoing evaluation for the Hs and Ts (hypoxia, hypovolemia, hydrogen ion [acidosis], hypo/hyperkalemia, hypothermia, tension pneumothorax, tamponade, toxins, thrombosis)

Despite optimal execution of these steps, approximately half of patients with initial VF may remain refractory after multiple defibrillation attempts.

Refractory VF is generally defined as:

• Persistent VF after three consecutive defibrillation attempts, each separated by 2 minutes of CPR, using standard pad positioning and appropriate energy levels.

Once VF becomes refractory, simply repeating identical shocks is often ineffective. This has prompted investigation into alternative defibrillation strategies aimed at:

• Altering the myocardial electrical vector

• Increasing delivered energy

• Improving myocardial voltage gradients

Vector-Change Defibrillation

Vector-change defibrillation involves relocating defibrillation pads from the standard anterior–lateral position to an anterior–posterior configuration. This changes the electrical pathway through the myocardium and may better capture regions of the left ventricle that are inadequately defibrillated with standard pad placement.

Double Sequential External Defibrillation (DSED)

Double sequential external defibrillation involves:

• Two defibrillators

• Two sets of pads placed in different planes (typically anterior–lateral and anterior–posterior)

• Two shocks delivered in rapid sequence (within <1 second), rather than simultaneously

Theoretical mechanisms include:

• Higher total delivered energy

• A “conditioning” first shock that alters myocardial refractoriness, allowing the second shock to terminate VF more effectively

• Improved voltage gradients in myocardial regions prone to re-initiating fibrillation

The DOSE VF trial, a multicenter cluster-randomized controlled trial conducted across six Canadian paramedic services, provides the strongest evidence to date evaluating these strategies.

In this study:

• Adult patients with out-of-hospital cardiac arrest and refractory VF after three standard defibrillation attempts were randomized to:

• Continued standard defibrillation

• Vector-change defibrillation

• Double sequential external defibrillation

Key Findings:

• Survival to hospital discharge was significantly higher in:

• DSED (30.4%) compared with standard defibrillation (13.3%)

• Vector-change defibrillation (21.7%) compared with standard defibrillation

• Good neurologic outcome (modified Rankin score ≤2) was significantly higher with DSED

• Rates of VF termination and return of spontaneous circulation were also highest in the DSED group

Importantly, these benefits were observed in the setting of:

• High-quality CPR

• Similar timing and dosing of epinephrine and antiarrhythmic medications across groups

• No reported defibrillator damage or safety concerns with DSED

These findings suggest that early escalation to vector-change defibrillation or DSED, rather than repeated identical shocks, may meaningfully improve outcomes in refractory VF.

This simulation is designed to:

• Demonstrate structured, team-based management of refractory ventricular fibrillation

• Highlight decision-making around escalation beyond standard defibrillation

• Reinforce the importance of CPR quality, timing, and coordination during high-acuity resuscitations

• Translate emerging evidence into practical bedside and prehospital application

While protocols and scope of practice vary by institution and region, the principles demonstrated reflect current evidence and evolving best practices in cardiac arrest management.

1. Cheskes S, Verbeek PR, Drennan IR, et al. Defibrillation Strategies for Refractory Ventricular Fibrillation. New England Journal of Medicine. 2022;387:1947–1956. DOI: 10.1056/NEJMoa2207304.
   NEJMoa2207304

2. American Heart Association. Adult Advanced Cardiovascular Life Support Guidelines. Circulation. 2015 & 2020 updates.

3. Kudenchuk PJ, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. New England Journal of Medicine. 2016.

4. Ideker RE, et al. Current Concepts for Selecting Defibrillation Electrode Location. Pacing and Clinical Electrophysiology. 1991.